Eine Plattform für die Wissenschaft: Bauingenieurwesen, Architektur und Urbanistik
Eine Plattform für die Wissenschaft: Bauingenieurwesen, Architektur und Urbanistik
QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORS
The invention includes methods of using compounds of Formula I as type I receptor tyrosine kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORS
The invention includes methods of using compounds of Formula I as type I receptor tyrosine kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORS
WALLACE ELI (Autor:in) / TOPALOV GEORGE (Autor:in) / LYSSIKATOS JOSEPH (Autor:in) / BUCKMELTER ALEXANDRE (Autor:in) / ZHAO QIAN (Autor:in)
16.09.2021
Patent
Elektronische Ressource
Englisch
Quinazoline analogs as receptor tyrosine kinase inhibitors
| Europäisches Patentamt | 2019
Quinazoline analogs as receptor tyrosine kinase inhibitors
| Europäisches Patentamt | 2017
QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORS
| Europäisches Patentamt | 2019
QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORS
| Europäisches Patentamt | 2017
Signal Transduction by EGF Receptor Tyrosine Kinase
| British Library Conference Proceedings | 1997